NCT07505875 Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX
| NCT ID | NCT07505875 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | Substance Use |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-05-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Able to communicate in Thai * Provide informed consent Exclusion Criteria: • Unable to participate in in-depth interview (IDI) (online or onsite)
Contact & Investigator
Nittaya Phanuphak, MD,PhD.
PRINCIPAL INVESTIGATOR
Institute of HIV Research and Innovation (IHRI)
Frequently Asked Questions
Who can join the NCT07505875 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07505875 currently recruiting?
Yes, NCT07505875 is actively recruiting participants. Contact the research team at nittaya.p@ihri.org for enrollment information.
Where is the NCT07505875 trial being conducted?
This trial is being conducted at Pathum Wan, Thailand.
Who is sponsoring the NCT07505875 clinical trial?
NCT07505875 is sponsored by Institute of HIV Research and Innovation Foundation, Thailand. The principal investigator is Nittaya Phanuphak, MD,PhD. at Institute of HIV Research and Innovation (IHRI). The trial plans to enroll 50 participants.